Direct cardio-protection of Dapagliflozin against obesity-related cardiomyopathy via NHE1/MAPK signaling
Ke Lin, Na Yang, Wu Luo, Jinfu Qian, Weiwei Zhu, Shiju Ye, Chen-xin Yuan, Diyun Xu, Guang Liang, Weijian Huang, Peiren Shan
Topics & Concepts
DapagliflozinDiabetic cardiomyopathyInflammationIn vivoApoptosisCardiomyopathyPharmacologyMAPK/ERK pathwayBiologyInternal medicineHeart failureEndocrinologyChemistryMedicineSignal transductionBiochemistryDiabetes mellitusType 2 diabetesBiotechnologyDiabetes Treatment and ManagementPancreatic function and diabetesCardiovascular Function and Risk Factors